- We will send in 10–14 business days.
/images/books/13482259/9786138947134.jpg)
- Author: Zainab Sabri Abbas
- Publisher: Scholars' Press
- ISBN-10: 6138947134
- ISBN-13: 9786138947134
- Format: 15.2 x 22.9 x 0.7 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Asthma therapeutic development by theophylline complex in nano-scale (e-book) (used book) | bookbook.eu
Reviews
Description
Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphate cGMP in target cells. The amount of serum PDE increases in the cyclic extracellular nucleotides. ln this book, we review A novel synthesis-therapy in nanoscale for asthma patients by inhibits phosphodiesterase enzyme.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.06:27:48
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Zainab Sabri Abbas
- Publisher: Scholars' Press
- ISBN-10: 6138947134
- ISBN-13: 9786138947134
- Format: 15.2 x 22.9 x 0.7 cm, softcover
- Language: English English
Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphate cGMP in target cells. The amount of serum PDE increases in the cyclic extracellular nucleotides. ln this book, we review A novel synthesis-therapy in nanoscale for asthma patients by inhibits phosphodiesterase enzyme.
Reviews